Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Pharmaids Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Pharmaids Pharmaceuticals Ltd

Mon 14/07/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 63.50

Previous Close

₹ 64.16

Volume

6333

Mkt Cap ( Rs. Cr)

₹218.10

High

₹ 63.50

Low

₹ 59.10

52 Week High

₹ 87.46

52 Week Low

₹ 31.90

Book Value Per Share

₹ 19.04

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Pharmaids Pharmaceuticals Ltd

Your Vote -

Buy

60.00%

Hold

30.00%

Sell

10.00%

60.00%

10 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Pharmaids Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Pharmaids Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

7 Jul 2025, 10:32AM Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025.
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Change in Management

4 Jul 2025, 5:09PM Appointment of Internal Auditor for the financial year 2025-26.
Pharmaids Pharma - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

4 Jul 2025, 5:06PM Disinvestment/Sale/Disposal of the entire Partnership stake held in Anugraha Chemicals (\Partnership Firm\), in one or more tranches.
Pharmaids Pharma - Outcome Of The Board Meeting

4 Jul 2025, 5:00PM Outcome of the Board Meeting held on Friday, July 07, 2025.
Pharmaids Pharma - Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St Mar

23 May 2025, 5:06PM Submission of Audited Financial Results along with Auditors report.
Pharmaids Pharma - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31St, 2025

23 May 2025, 5:05PM The Board of Directors of the Company have approved the Audited Financial Results for the Quarter and Year ended March 31st 2025 at their meeting held
Pharmaids Pharma - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Conso

20 May 2025, 11:08AM Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to con
Pharmaids Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

17 Apr 2025, 4:10PM As of March 2025, 5.22% is owned by Indian Promoters and 94.78% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ph

Key fundamentals

Evaluate the intrinsic value of Pharmaids Pharmaceuticals Ltd stock

Name	March-24	March-23	March-22	March-21	March-20
Assets	83.5609	22.4252	8.6715	8.5264	8.4331
Liabilities	83.5609	22.4252	8.6715	8.5264	8.4331
Equity	35.2678	21.4438	10.2688	10.2688	10.2688
Gross Profit	-6.3711	-9.8862	0.137	0.1069	-0.3355
Net Profit	-4.9498	-7.5556	0.1451	0.0933	0.0335
Cash From Operating Activities	-3.4432	-4.0193	-0.2593	0.4053	-0.7475
NPM(%)	-17805.03	0	3.68	1.09	0
Revenue	0.0278	0	3.9392	8.551	0
Expenses	6.3989	9.8862	3.8021	8.444	0.3355
ROE(%)	-7.37	-11.25	0.21	0.13	0.04

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2023	2024	Equity Share	45.00	35.27	35267812.00	10	35.27
2022	2023	Equity Share	30.00	21.49	21486234.00	10	21.49
2021	2022	Equity Share	11.00	10.31	10311234.00	10	10.31
2020	2021	Equity Share	11.00	10.31	10311234.00	10	10.31
2019	2020	Equity Share	11.00	10.31	10311234.00	10	10.31
2017	2018	Equity Share	4.00	3.41	3405500.00	10	3.41
2016	2017	Equity Share	4.00	3.41	3405500.00	10	3.41
2015	2016	Equity Share	4.00	3.41	3405500.00	10	3.41
2014	2015	Equity Share	4.00	3.41	3405500.00	10	3.41
2013	2014	Equity Share	4.00	3.41	3405500.00	10	3.41
2012	2013	Equity Share	4.00	3.41	3405500.00	10	3.41
2011	2012	Equity Share	4.00	3.41	3405500.00	10	3.41
2010	2011	Equity Share	4.00	3.41	3405500.00	10	3.41
2009	2010	Equity Share	4.00	3.41	3405500.00	10	3.41
2008	2009	Equity Share	4.00	3.41	3405500.00	10	3.41
2007	2008	Equity Share	4.00	3.41	3405500.00	10	3.41
2006	2007	Equity Share	4.00	3.41	3405500.00	10	3.41
2004	2005	Equity Share	4.00	3.41	3405500.00	10	3.41
2002	2003	Equity Share	4.00	3.41	3405500.00	10	3.41
2001	2002	Equity Share	4.00	3.41	3405500.00	10	3.41
1999	2000	Equity Share	4.00	3.41	3405500.00	10	3.41
1995	1999	Equity Share	4.00	3.41	3405500.00	10	3.41
1994	1995	Equity Share	4.00	3.41	3405500.00	10	3.41
1993	1994	Equity Share	4.00	0.21	208700.00	10	0.21

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Pharmaids Pharmaceuticals Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	932.95	3.17	31.25	36.62	301.39	0.53
Lotus Eye Hospital and Institute Ltd	73.60	1.09	213.49	133.43	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	23.36	2.01	0.00	277.04	-39.50	0.00
Astec Lifesciences Ltd	931.15	4.23	0.00	125.83	-601.21	0.00

Company Info

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

Read More

Parent Organisation

Pharmaids Pharmaceuticals Ltd.

Founded

01/03/1989

Managing Director

NSE Symbol

FAQ

The current price of Pharmaids Pharmaceuticals Ltd is ₹ 61.84.

The 52-week high for Pharmaids Pharmaceuticals Ltd is

The market capitalization of Pharmaids Pharmaceuticals Ltd is currently ₹ 218.10. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Pharmaids Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Pharmaids Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Pharmaids Pharmaceuticals Ltd shares.

The CEO of Pharmaids Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT